Ftse Mib
34.816,78
-1,64%
DAX
18.768,96
0,33%
S&P 500
5.311,22
0,15%
NASDAQ
16.794,75
0,65%
Bitcoin
69.251,04
4,67%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Ra Pharmaceuticals Inc (RARX) Ra Pharmaceuticals Inc (RARX) Notizie

RARX

Ra Pharmaceuticals (RARX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RARX
DataOraFonteTitoloSimboloCompagnia
13/04/202012:03Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:RARXRa Pharmaceuticals Inc
09/04/202012:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RARXRa Pharmaceuticals Inc
06/04/202020:09Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RARXRa Pharmaceuticals Inc
03/04/202022:45Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:RARXRa Pharmaceuticals Inc
03/04/202015:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RARXRa Pharmaceuticals Inc
02/04/202022:09Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:RARXRa Pharmaceuticals Inc
02/04/202022:05Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:RARXRa Pharmaceuticals Inc
02/04/202022:03Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:RARXRa Pharmaceuticals Inc
02/04/202022:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RARXRa Pharmaceuticals Inc
02/04/202015:14Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:RARXRa Pharmaceuticals Inc
28/02/202013:00Business WireRa Pharmaceuticals Supports 13th Annual Rare Disease Day® and Joins Global Movement to Raise Awareness for Rare DiseasesNASDAQ:RARXRa Pharmaceuticals Inc
27/02/202013:00Business WireRa Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate UpdateNASDAQ:RARXRa Pharmaceuticals Inc
27/02/202012:26Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RARXRa Pharmaceuticals Inc
26/02/202022:05GlobeNewswire Inc.CRISPR Therapeutics Proposes Changes to the Board of DirectorsNASDAQ:RARXRa Pharmaceuticals Inc
18/02/202013:00Business WireRa Pharmaceuticals Announces Publication of Zilucoplan Phase 2 gMG Trial Results in JAMA NeurologyNASDAQ:RARXRa Pharmaceuticals Inc
10/02/202013:37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RARXRa Pharmaceuticals Inc
22/01/202015:00Business WireRa Pharmaceuticals Announces Clearance of IND Application for the HEALEY ALS Platform TrialNASDAQ:RARXRa Pharmaceuticals Inc
06/12/201923:15Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:RARXRa Pharmaceuticals Inc
04/12/201913:00Business WireRa Pharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of Zilucoplan for IMNMNASDAQ:RARXRa Pharmaceuticals Inc
03/12/201923:45PR Newswire (US)Moore Kuehn, PLLC Encourages Liberty Property Trust (LPT), Proteon Therapeutics (PRTO), Ra Pharmaceuticals (RARX), Carolina T...NASDAQ:RARXRa Pharmaceuticals Inc
15/11/201914:03Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:RARXRa Pharmaceuticals Inc
08/11/201915:05Edgar (US Regulatory)Schedule 13gNASDAQ:RARXRa Pharmaceuticals Inc
07/11/201913:00Business WireRa Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:RARXRa Pharmaceuticals Inc
07/11/201912:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RARXRa Pharmaceuticals Inc
01/11/201913:25Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:RARXRa Pharmaceuticals Inc
10/10/201920:21PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Ra Pharmaceuticals, Inc.NASDAQ:RARXRa Pharmaceuticals Inc
10/10/201914:12PR Newswire (US)Ra Pharma (RARX) Alert: Johnson Fistel Investigates Proposed Sale of Ra Pharmaceuticals; Is $48 a Fair Price?NASDAQ:RARXRa Pharmaceuticals Inc
10/10/201913:00PR Newswire (US)UCB Agrees to Acquire Ra Pharmaceuticals: Joining Forces to Improve Treatment Options for People Living With Myasthenia Gravi...NASDAQ:RARXRa Pharmaceuticals Inc
02/10/201913:00Business WireRa Pharmaceuticals Announces Dosing of First Patient in Global Phase 3 Pivotal Study of Zilucoplan for gMGNASDAQ:RARXRa Pharmaceuticals Inc
18/09/201913:00Business WireRa Pharmaceuticals Announces Selection for the First ALS Platform Trial by the Sean M. Healey & AMG Center for ALS at Mass Ge...NASDAQ:RARXRa Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RARX

La tua Cronologia

BIT
P1YJY2
NLBNPIT1YJY2 20991231 46...
EU
DEZG
Euronext Developed Euroz...
BIT
P1TEJ4
NLBNPIT1TEJ4 20240621 35
BIT
P1XTD7
NLBNPIT1XTD7 20991231 11...
BIT
UI362X
UniCredit
ZBCM
XLMUSDT
Stellar Lumens
BIT
P1VYM2
NLBNPIT1VYM2 20991231 3....
BOV
Z1TS34
Zoetis
EU
SUAH
Schneider Electric SE 1....
BIT
P1YT68
NLBNPIT1YT68 20351219 10...
BIT
P1XBA1
NLBNPIT1XBA1 20991231 81...
NYSE
SCE.PRJ
SCE TR IV
BIT
P20NF3
NLBNPIT20NF3 20991231 2....
CSE
BLR.WT
Blackhawk Growth
BIT
P1XH55
NLBNPIT1XH55 20240620 4600
COIN
POTSUST
Moonpot
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network